RGNX peer analysis
REGENXBIO (RGNX) against its competitors: price, today's move, 1-year return and market value side by side.
RGNX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| FDMT 4D Molecular | $12.28 | 2.72% | 9.40% | – |
| GNPX Genprex | $2.31 | 3.59% | -98.02% | $1.89M |
| LXEO Lexeo Therapeutics | $3.24 | 4.18% | -64.16% | – |
| MGTX MeiraGTx | $9.42 | -1.05% | 7.90% | $914.33M |
| OCGN Ocugen | $0.88 | 17.94% | -42.93% | $252.71M |
| PGEN Precigen | $4.95 | -5.71% | 18.99% | $1.88B |
| QURE uniQure | $23.05 | -3.44% | -32.78% | $1.66B |
| RCKT Rocket Pharmaceuticals | $2.66 | 5.98% | -25.28% | $275.53M |
| SLDB Solid Biosciences | $6.50 | 3.50% | 25.00% | $673.37M |
| VYGR Voyager Therapeutics | $1.88 | 2.73% | -59.04% | $112.76M |
| RGNX REGENXBIO | $7.74 | 1.44% | -35.45% | $503.68M |
- RGNX's peers: FDMT (4D Molecular), GNPX (Genprex), LXEO (Lexeo Therapeutics), MGTX (MeiraGTx), OCGN (Ocugen), PGEN (Precigen), QURE (uniQure), RCKT (Rocket Pharmaceuticals).
Updated 2026-11-05 12:51 UTC